1. Home
  2. EPIX vs GCTS Comparison

EPIX vs GCTS Comparison

Compare EPIX & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • GCTS
  • Stock Information
  • Founded
  • EPIX 2009
  • GCTS 1998
  • Country
  • EPIX Canada
  • GCTS United States
  • Employees
  • EPIX N/A
  • GCTS N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • GCTS Blank Checks
  • Sector
  • EPIX Health Care
  • GCTS Finance
  • Exchange
  • EPIX Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • EPIX 75.9M
  • GCTS 82.5M
  • IPO Year
  • EPIX N/A
  • GCTS N/A
  • Fundamental
  • Price
  • EPIX N/A
  • GCTS $1.46
  • Analyst Decision
  • EPIX Hold
  • GCTS Strong Buy
  • Analyst Count
  • EPIX 3
  • GCTS 1
  • Target Price
  • EPIX $2.00
  • GCTS $5.00
  • AVG Volume (30 Days)
  • EPIX 57.6K
  • GCTS 999.8K
  • Earning Date
  • EPIX 08-04-2025
  • GCTS 08-13-2025
  • Dividend Yield
  • EPIX N/A
  • GCTS N/A
  • EPS Growth
  • EPIX N/A
  • GCTS N/A
  • EPS
  • EPIX N/A
  • GCTS N/A
  • Revenue
  • EPIX N/A
  • GCTS $6,359,000.00
  • Revenue This Year
  • EPIX N/A
  • GCTS $133.55
  • Revenue Next Year
  • EPIX N/A
  • GCTS $347.37
  • P/E Ratio
  • EPIX N/A
  • GCTS N/A
  • Revenue Growth
  • EPIX N/A
  • GCTS N/A
  • 52 Week Low
  • EPIX $1.40
  • GCTS $0.90
  • 52 Week High
  • EPIX $7.88
  • GCTS $5.45
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 50.49
  • GCTS 52.78
  • Support Level
  • EPIX $1.67
  • GCTS $1.41
  • Resistance Level
  • EPIX $1.73
  • GCTS $1.53
  • Average True Range (ATR)
  • EPIX 0.04
  • GCTS 0.13
  • MACD
  • EPIX -0.00
  • GCTS 0.01
  • Stochastic Oscillator
  • EPIX 55.56
  • GCTS 30.50

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: